Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMIC ADV ETF
-
Total 13F shares
-
155,206
-
Share change
-
-118,398
-
Total reported value
-
$7,526,219
-
Price per share
-
$48.42
-
Number of holders
-
11
-
Value change
-
-$6,279,456
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) as of Q4 2021
As of 31 Dec 2021 FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 155,206 shares of stock of the company.
Largest 10 holders included JANE STREET GROUP, LLC, COMMONWEALTH EQUITY SERVICES, LLC, FLOW TRADERS U.S. LLC, American Portfolios Advisors, LPL Financial LLC, BENJAMIN F. EDWARDS & COMPANY, INC., Spire Wealth Management, UBS Group AG, ADVISOR GROUP HOLDINGS, INC., and HARBOUR INVESTMENTS, INC..
This table shows 11 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.